Assessment of the diagnostic efficacy of radiological and functional evaluation of primary adrenal mass and its’ surgical outcomes

Abstract

Introduction:

Objective of this study was to assess the diagnostic efficacy of the most commonly used radiological evaluation in form of contrast enhanced computed tomography of abdomen with adrenal protocol, basic functional evaluation and surgical outcomes of primary adrenal masses.

Material and methods:

We have retrospectively analysed the institutional records of 108, patients admitted from August 2017 to September 2023, who had underwent surgical intervention for their adrenal mass after thorough evaluation and stabilization.

Results:

Flank pain was the most common symptoms in 44 (40.74%) patients. Non-functional adrenal adenoma was found in 36 (33.33%) patients. Pheochromocytoma was the most the common functional adrenal mass found in 24 (22.22%) patients. CECT abdomen had suggested features of malignancy in 16(14.81%) patients. In final histopathological report 26(24.07%) patients had pheochromocytoma and 12 (11.11%) patients had adrenocortical carcinoma. CECT abdomen had sensitivity of 75%, specificity of 95.6%. Plasma free metanephrines and normetanephrine analysis had shown sensitivity of 90%, specificity of 92.86%, aldosterone to renin ratio had sensitivity of 92%, specificity of 100%. Sensitivity and specificity of the low-dose dexamethasone suppression test and plasma dehydroepiandrosterone was 100% in our study. Eighty patients (74.07%) were operated with laparoscopic adrenalectomy, 20 (18.52%) patients with open adrenalectomy. Eight patients (7.41%) were converted from laparoscopic to open. Laparoscopic approach had significantly lesser mean operating time, lesser blood loss, lesser hospitalization and lesser post-operative complications.

Conclusion:

Radiological analysis and functional analysis has shown good sensitivity and high specificity. Laparoscopic approach has advantage of lesser operative time, lesser hospitalization and lesser post-operative complications.

Keywords

Laparoscopic adrenalectomy adrenal mass radiological evaluation functional evaluation sensitivity and specificity

Get full access to this article

View all access options for this article.

References

Grumbach

Biller

Braunstein

, et al Management of the clinically inapparent adrenal mass (‘incidentaloma’). Ann Intern Med 2003; 138(5): 424–429.

Fassnacht

Tsagarakis

Terzolo

, et al; European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol 2023; 189(1): G1–G42.

Shanmugam

Susikar

Raja

, et al Adrenal tumours: 10-year experience of a tertiary cancer centre. Int Surg J 2021; 8: 2420–2423.

Zeiger

Thompson

Duh

, et al American Association of Clinical Endocrinologists; American Association of Endocrine Surgeons. American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas: executive summary of recommendations. Endocr Pract 2009; 15(5): 450–453.

Aron

DC.

The adrenal incidentaloma: disease of modern technology and public health problem. Rev Endocr Metab Disord 2001; 2(3): 335–342.

Khanna

Priya

Bhartiya

, et al Adrenal tumors: an experience of 10 years in a single surgical unit. Indian J Cancer 2015; 52(3): 475–478.

Hao

Lopez

Luque-Fernandez

, et al The lateralizing asymmetry of adrenal adenomas. J Endocr Soc 2018; 2(4): 374–385.

Lee

Kim

, et al; Korean Endocrine Society, Committee for Clinical Practice Guidelines. Clinical guidelines for the management of adrenal incidentaloma. Endocrinol Metab (Seoul) 2017; 32(2): 200–218.

Rafiq

Nabi

Dar

, et al Presentation and outcome of patients with an adrenal mass: a retrospective observational study. Clin Cancer Investig J 2020; 9(5): 198–204.

10.

Cawood

Hunt

O’Shea

, et al

Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink?

Eur J Endocrinol

2009; 161(4): 513–527.

11.

Hung

Ahmed

Gupta

, et al Performance of the aldosterone to renin ratio as a screening test for primary aldosteronism. J Clin Endocrinol Metab 2021; 106(8): 2423–2435.

12.

Shen

Sturgeon

Duh

QY.

From incidentaloma to adrenocortical carcinoma: the surgical management of adrenal tumors. J Surg Oncol 2005; 89(3): 186–192.

13.

Bharwani

Rockall

Sahdev

, et al Adrenocortical carcinoma: the range of appearances on CT and MRI. AJR Am J Roentgenol 2011; 196(6): W706–W714.

14.

Hamrahian

Ioachimescu

Remer

, et al Clinical utility of noncontrast computed tomography attenuation value (hounsfield units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: cleveland clinic experience. J Clin Endocrinol Metab 2005; 90(2): 871–877.

15.

Lee

Hahn

Papanicolaou

, et al Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 1991; 179(2): 415–418.

16.

Iñiguez-Ariza

Kohlenberg

Delivanis

, et al Clinical, biochemical, and radiological characteristics of a single-center retrospective cohort of 705 large adrenal tumors. Mayo Clin Proc Innov Qual Outcomes 2017; 2(1): 30–39.

17.

Sturgeon

Kebebew

Laparoscopic adrenalectomy for malignancy. Surg Clin North Am 2004; 84(3): 755–774.

18.

NIH state-of-the-science statement on management of the clinically in apparent adrenal mass (‘incidentaloma’). NIH Consens State Sci Statements 2002; 19(2): 1–25.

19.

Gumbs

Gagner

Laparoscopic adrenalectomy. Best Pract Res Clin Endocrinol Metab 2006; 20(3): 483–499.

20.

Zorgani

Pirie

Motala

AA.

Characteristics and outcome of patients with pheochromocytoma at a tertiary endocrinology clinic in Durban, South Africa over 14 years. J Endocrinol Metab Diabetes South Afr 2018; 23: 52–58.